The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Neuroprotective Properties of Statins in Cerebral Ischemia and Stroke
Open accessAbstract
Background —The atheroma-retarding properties of β-hydroxy-β-methylglutaryl coenzyme A reductase (HMG-CoA) inhibitors, or “statins,” in both the coronary and carotid arterial beds are well established. However, a growing body of recent data suggests that statins possess important adjunctive properties that may confer additional benefit beyond the retardation of atherosclerosis. In this article, we review the emerging evidence that statins have beneficial effects within the cerebral circulation and brain parenchyma during ischemic stroke and reperfusion. Summary of Review —Clinical studies show that statins reduce the incidence of ischemic stroke through probable effects on precerebral atherosclerotic plaque and through antithrombotic mechanisms. Additionally, statins have been shown to reduce infarct size in experimental animal models of stroke. Statins both upregulate endothelial nitric oxide synthase (eNOS) and inhibit inducible nitric oxide synthase (iNOS), effects that are potentially neuroprotective. The preservation of eNOS activity in cerebral vasculature, particularly in the ischemic penumbra, may be especially important in preserving blood flow and limiting neurological loss. Statins may also attenuate the inflammatory cytokine responses that accompany cerebral ischemia, and they possess antioxidant properties that likely ameliorate ischemic oxidative stress in the brain. Conclusions —In addition to reducing stroke, the statin class of drugs exhibits a number of important neuroprotective properties that likely attenuate the effects of ischemia on the brain vasculature and parenchyma. Further investigation of the role of statins in human neuroprotection by use of neuroimaging and cognitive studies is warranted to explore these preliminary observations. In addition to reducing ischemic stroke, early evidence indicates that statins may also be neuroprotective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Iso, H., Jacobs, D. R., Wentworth, D., Neaton, J. D., Cohen, J. D., & for the MRFIT Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201405 · Cited by 1,133
Role of Oxidants in Ischemic Brain Damage
Chan, P. H. (1996) · Stroke · doi:10.1161/01.str.27.6.1124 · Cited by 1,032
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 966
Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month
O'Driscoll, G., Green, D., & Taylor, R. R. (1997) · Circulation · doi:10.1161/01.cir.95.5.1126 · Cited by 952
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S., & Gimbrone, M. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.618 · Cited by 935
Bruce, A. J., Boling, W., Kindy, M. S., Peschon, J., Kraemer, P. J., Carpenter, M. K., Holtsberg, F. W., & Mattson, M. P. (1996) · Nature Medicine · doi:10.1038/nm0796-788 · Cited by 932
(1995) · The Lancet · doi:10.1016/s0140-6736(95)92836-7 · Cited by 856
Huang, Z., Huang, P. L., Ma, J., Meng, W., Ayata, C., Fishman, M. C., & Moskowitz, M. A. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00023 · Cited by 718
Statins do more than just lower cholesterol
Vaughan, C. J., Murphy, M. B., & Buckley, B. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05190-2 · Cited by 698
Self-citationIadecola, C., Zhang, F., Casey, R., Nagayama, M., & Ross, M. E. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09157.1997 · Cited by 661
Nitric Oxide Synthase in Models of Focal Ischemia
Samdani, A. F., Dawson, T. M., & Dawson, V. L. (1997) · Stroke · doi:10.1161/01.str.28.6.1283 · Cited by 656
Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)
Crouse, J. R., Byington, R. P., Bond, M. G., Espefand, M. A., Craven, T. E., Sprinkle, J. W., McGovern, M. E., & Furberg, C. D. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80580-3 · Cited by 609
Egashira, K., Hirooka, Y., Kai, H., Sugimachi, M., Suzuki, S., Inou, T., & Takeshita, A. (1994) · Circulation · doi:10.1161/01.cir.89.6.2519 · Cited by 597
Pahan, K., Sheikh, F. G., Namboodiri, A. M., & Singh, I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119812 · Cited by 571
Matthews, R. T., Yang, L., Browne, S., Baik, M., & Beal, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8892 · Cited by 557
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A. J., Old, L., & Bernard, C. C. A. (1998) · Nature Medicine · doi:10.1038/nm0198-078 · Cited by 550
Loddick, S. A., & Rothwell, N. J. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00017 · Cited by 463
Lovastatin decreases coenzyme Q levels in humans.
Folkers, K., Langsjoen, P., Willis, R., Richardson, P., Xia, L. J., Ye, C. Q., & Tamagawa, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8931 · Cited by 426
Weber, C., Erl, W., Weber, K. S. C., & Weber, P. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00324-0 · Cited by 411
Dimmeler, S., Haendeler, J., Galle, J., & Zeiher, A. M. (1997) · Circulation · doi:10.1161/01.cir.95.7.1760 · Cited by 371
Chopp, M., Zhang, R. L., Chen, H., Li, Y., Jiang, N., & Rusche, J. R. (1994) · Stroke · doi:10.1161/01.str.25.4.869 · Cited by 343
Interleukin-1 beta mRNA expression in ischemic rat cortex.
Liu, T., McDonnell, P. C., Young, P. R., White, R. F., Siren, A. L., Hallenbeck, J. M., Barone, F. C., & Feurestein, G. Z. (1993) · Stroke · doi:10.1161/01.str.24.11.1746 · Cited by 333
Blauw, G. J., Lagaay, A. M., Smelt, A. H. M., & Westendorp, R. G. J. (1997) · Stroke · doi:10.1161/01.str.28.5.946 · Cited by 311
Aviram, M., Rosenblat, M., Bisgaier, C. L., & Newton, R. S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00032-x · Cited by 296
Reductase Inhibitor Monotherapy and Stroke Prevention
Crouse, J. R. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.12.1305 · Cited by 221
Chen, L., Haught, W. H., Yang, B., Saldeen, T. G. P., Parathasarathy, S., & Mehta, J. L. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00158-7 · Cited by 208
Bryan, R. N., Wells, S. W., Miller, T. J., Elster, A. D., Jungreis, C. A., Poirier, V. C., Lind, B. K., & Manolio, T. A. (1997) · Radiology · doi:10.1148/radiology.202.1.8988191 · Cited by 203
Effects of Fluvastatin on Leukocyte–Endothelial Cell Adhesion in Hypercholesterolemic Rats
Kimura, M., Kurose, I., Russell, J., & Granger, D. N. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.8.1521 · Cited by 193
Inducible nitric oxide synthase expression in human cerebral infarcts
Forster, C., Clark, H. B., Ross, M. E., & Iadecola, C. (1999) · Acta Neuropathologica · doi:10.1007/s004010050977 · Cited by 187
Hussein, O., Schlezinger, S., Rosenblat, M., Keidar, S., & Aviram, M. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)05972-2 · Cited by 176
Vascular Effects of Statins in Stroke
Delanty, N., & Vaughan, C. J. (1997) · Stroke · doi:10.1161/01.str.28.11.2315 · Cited by 151
Self-citationPantoni, L., Sarti, C., & Inzitari, D. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.4.503 · Cited by 150
Inducible Nitric-oxide Synthase and Nitric Oxide Production in Human Fetal Astrocytes and Microglia
Ding, M., Pierre, B. A. S., Parkinson, J. F., Medberry, P. S., Wong, J. L., Rogers, N. E., Ignarro, L. J., & Merrill, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11327 · Cited by 147
Oxidative injury in the nervous system
Delanty, N., & Dichter, M. A. (1998) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb07285.x · Cited by 137
Self-citationAird, I. (1952) · BMJ · doi:10.1136/bmj.2.4790.923 · Cited by 108
Differential regulation by cytokines of human astrocyte nitric oxide production
Hu, S., Sheng, W. S., Peterson, P. K., & Chao, C. C. (1995) · Glia · doi:10.1002/glia.440150412 · Cited by 90
Human, J. A., Ubbink, J., Jerling, J. C., Delport, R., Vermaak, W. J. H., Vorster, H. H., Lagendijk, J., & Potgieter, H. C. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)06557-1 · Cited by 59
Chiloeches, A., Usera, F., Lasa, M., Ropero, S., Montes, A., & Toro, M. J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01434-2 · Cited by 10
Cited by
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 905
Statin Adverse Effects: A Review of the Literature and Evidence for a Mitochondrial Mechanism
Golomb, B. A., & Evans, M. A. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/0129784-200808060-00004 · Cited by 677
Cellular Antioxidant Effects of Atorvastatin In Vitro and In Vivo
Wassmann, S., Laufs, U., Müller, K., Konkol, C., Ahlbory, K., Bäumer, A. T., Linz, W., Böhm, M., & Nickenig, G. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0202.104081 · Cited by 592
Casserly, I., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15900-x · Cited by 560
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Metadata
- Authors
- Vaughan, C. J., & Delanty, N.
- Venue
- Stroke
- Published
- 1999-09
- Volume
- 30
- Issue
- 9
- Pages
- 1969-1973
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2063738580
- Cited by
- 386
- References
- 41
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.